Connection

Co-Authors

This is a "connection" page, showing publications co-authored by CHRIS AMOS and CHAO CHENG.
Connection Strength

1.088
  1. Statins associate with improved mortality among patients with certain histological subtypes of lung cancer. Lung Cancer. 2018 12; 126:89-96.
    View in: PubMed
    Score: 0.171
  2. Predictors of disease aggressiveness influence outcome from immunotherapy treatment in renal clear cell carcinoma. Oncoimmunology. 2019; 8(1):e1500106.
    View in: PubMed
    Score: 0.171
  3. Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics. Melanoma Res. 2018 10; 28(5):380-389.
    View in: PubMed
    Score: 0.170
  4. A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis. Mol Cancer Res. 2019 01; 17(1):109-119.
    View in: PubMed
    Score: 0.169
  5. Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy. Oncoimmunology. 2018; 7(6):e1431084.
    View in: PubMed
    Score: 0.164
  6. A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2018 01; 27(1):86-95.
    View in: PubMed
    Score: 0.160
  7. Characterizing the heterogeneity in 5-aminolevulinic acid-induced fluorescence in glioblastoma. J Neurosurg. 2019 May 24; 132(6):1706-1714.
    View in: PubMed
    Score: 0.044
  8. Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients. PLoS One. 2017; 12(4):e0175850.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.